Browsing: Trial

Prosecutors pointed to internet searches made on the family computer in the months before the killings to make their case

Defense attorneys say Lindsay Clancy isn’t criminally responsible for the deaths of her children because she was experiencing postpartum psychosis. See all topics

Ascletis Pharma (SEHK:1672) has drawn fresh attention after launching two Phase I obesity trials in the U.S. and starting a global Phase III program for its oral GLP-1 candidate ASC30

Spain leads the EU in clinical trials, according to 2025 approval data that show that nearly 1,000 studies were greenlit in the country last year

Jurors in the murder trial of Lindsay Clancy spent much of the past week hearing testimony from psychiatrists, therapists and other medical professionals as attorneys continued to battle over whether the Massachusetts mother was experiencing postpartum psychosis when her three children were killed in 2023, Newsweek reported

Feed rapamycin to old mice and they live 9 to 14 percent longer, even when you start dosing them in the rodent equivalent of late middle age (extends lifespan). That single result, reproduced across three independent labs, is a big part of why rapamycin became the most talked-about molecule in the longevity space. So when…

Jurors hear from host of medical experts as defence says postpartum psychosis caused young mother to kill children

Neurocrine Biosciences has initiated a Phase 1 clinical trial to test the safety and tolerability of NBIP-‘1968, a novel triple agonist drug targeting GLP-1, GIP, and glucagon receptors for obesity treatment. This investigational drug aims to address obesity by engaging three metabolic mechanisms to regulate appetite, energy balance, and glycemic control. The study will involve…

Lindsay Clancy waits for the judge to call a prospective jury member into court in her murder trial where she is charged in the 2023 killing of her three children, Wednesday, July 22, 2026, in Plymouth Superior Court in Plymouth, Mass. (Greg Derr/The Patriot Ledger

ADAR1 inhibitor researched in outer space holds promise for AML and myelofibrosis now — and possibly cancers like glioblastoma multiforme in the future